Last reviewed · How we verify
NCT03237884: IZERZO
Romanian-Swiss Research Programme IZERZO
trial in Advanced Incurable Cancer in 308 participants. Completed in 31 December 2016.
31 December 2016
Quick facts
| Lead sponsor | Cantonal Hospital of St. Gallen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 308 |
| Start date | 1 January 2013 |
| Primary completion | 31 December 2016 |
| Estimated completion | 31 December 2016 |
| Sites | 2 locations across Romania, Switzerland |
Conditions studied
- Advanced Incurable Cancer — all drugs for Advanced Incurable Cancer →
Sponsor
Cantonal Hospital of St. Gallen
Who can join
18 and older, any sex, with Advanced Incurable Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Palliative Care procedures should be integrated early in the course of disease of patients with advanced incurable cancer. With this study, where the investigators follow adult patients with incurable cancer over 6 months or until death (whatever occurs earlier), the investigators aim to identify patients' needs for Palliative Care interventions (like support in illness understanding and decision making, symptom management, concrete end-of-life preparation, and others) and their remembered delivery by health care professionals. The investigators also collect data on patients care (use of chemotherapy, intensive care in the last month of life) and quality of death and dying (assessed by post-death-interviews with bereaved relatives). The aim is to have a "reality map" on current integration of oncology and palliative care and to test if appropriate Palliative Care interventions predict a better outcome.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Constricting Gaps: Protocol development, implementation challenges and lessons learned for the <i>r</i>eality m<i>a</i>p of un<i>m</i>et needs for <i>P</i>alliative Care <i>I</i>nterventions in advanced <i>c</i>ancer patient<i>s</i> study in Romania and Switzerland.
Kalbermatten N, Curca R, Grigorescu A, Mosoiu D, et al · · 2024 · PMID 39351079 · DOI 10.1016/j.conctc.2024.101360
Verify or expand the search:
- PubMed search for NCT03237884
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cantonal Hospital of St. Gallen trials
Trials by the same sponsor.
- NCT07483112 — Fiber-Boost Randomized Controlled Trial · NA · recruiting
- NCT06279000 — Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery · Phase 3 · recruiting
- NCT06703814 — PROtective Ventilation With FLOW-Controlled Ventilation · NA · recruiting
- NCT06256900 — Flow Controlled Ventilation in Robot-assisted Laparoscopic Surgery · NA · withdrawn
- NCT06505863 — Quality of Life After Transanal Total Mesorectal Excision Compared to Traditional Total Mesorectal Excision · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03237884 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cantonal Hospital of St. Gallen
- Last refreshed: 3 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03237884.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing